ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 154
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
NITYR 10MG TBL NOB 60
0223045 EU/1/18/1290/001 nityr.pdf nityr.pdf A16AX04 R
ORFADIN 5MG CPS DUR 60
0028408 EU/1/04/303/002 orfadin.pdf orfadin.pdf A16AX04 R
ORFADIN 2MG CPS DUR 60
0028407 EU/1/04/303/001 orfadin.pdf orfadin.pdf A16AX04 R
ORFADIN 20MG CPS DUR 60
0210410 EU/1/04/303/004 orfadin.pdf orfadin.pdf A16AX04 R
ORFADIN 4MG/ML POR SUS 1X90ML
0210495 EU/1/04/303/005 orfadin.pdf orfadin.pdf A16AX04 R
ORFADIN 10MG CPS DUR 60
0028409 EU/1/04/303/003 orfadin.pdf orfadin.pdf A16AX04 R
OXLUMO 94,5MG/0,5ML INJ SOL 1X0,5ML
0250225 EU/1/20/1496/001 oxlumo.pdf oxlumo.pdf A16AX18 R
PALYNZIQ 2,5MG INJ SOL 1X0,5ML
0238467 EU/1/19/1362/001 palynziq.pdf palynziq.pdf A16AB19 R
PALYNZIQ 20MG INJ SOL 10X1ML
0238470 EU/1/19/1362/004 palynziq.pdf palynziq.pdf A16AB19 R
PALYNZIQ 20MG INJ SOL 1X1ML
0238469 EU/1/19/1362/003 palynziq.pdf palynziq.pdf A16AB19 R
PALYNZIQ 10MG INJ SOL 1X0,5ML
0238468 EU/1/19/1362/002 palynziq.pdf palynziq.pdf A16AB19 R
PHEBURANE 483MG/G GRA 1X174G
0194299 EU/1/13/822/001 pheburane.pdf pheburane.pdf A16AX03 R
PROCYSBI 75MG CPS ETD 250
0194405 EU/1/13/861/002 procysbi.pdf procysbi.pdf A16AA04 R
PROCYSBI 25MG CPS ETD 60
0194404 EU/1/13/861/001 procysbi.pdf procysbi.pdf A16AA04 R
RAVICTI 1,1G/ML POR LIQ 1X25ML I
0209081 EU/1/15/1062/001 ravicti.pdf ravicti.pdf A16AX09 R
REPLAGAL 1MG/ML INF CNC SOL 4X3,5ML
0027288 EU/1/01/189/002 replagal.pdf replagal.pdf A16AB03 R
REPLAGAL 1MG/ML INF CNC SOL 1X3,5ML
0027287 EU/1/01/189/001 replagal.pdf replagal.pdf A16AB03 R
REPLAGAL 1MG/ML INF CNC SOL 10X3,5ML
0027289 EU/1/01/189/003 replagal.pdf replagal.pdf A16AB03 R
REVESTIVE 5MG INJ PSO LQF 28+28X0,5ML ISP
0193528 EU/1/12/787/001 revestive.pdf revestive.pdf A16AX08 R
REVESTIVE 1,25MG INJ PSO LQF 28+28X0,5ML ISP
0222233 EU/1/12/787/003 revestive.pdf revestive.pdf A16AX08 R

‹‹ ‹ 1 2 3 4 5 6 7 8 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 10. August 2022 at 01:08
Last update of price and payment data: 30. July 2022 at 01:10